Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Financial Statements Details - Accrued and Other Liabilities (Details)

v3.25.1
Consolidated Financial Statements Details - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Accrued and other liabilities    
Accrued short-term interest payable $ 3,039 $ 535
Accrued incentive compensation 1,555 1,203
Accrued clinical liabilities 306  
Income taxes payable in connection with Pulmokine acquisition 280  
Accrued legal and accounting fees 251 791
Accrued payroll and benefits 170 149
Other accrued liabilities 151 90
Total $ 5,752 $ 2,768